Literature DB >> 17360460

Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.

Hui Wu1, Susan A Boackle, Punchong Hanvivadhanakul, Daniela Ulgiati, Jennifer M Grossman, Youngho Lee, Nan Shen, Lawrence J Abraham, Timothy R Mercer, Elly Park, Lee A Hebert, Brad H Rovin, Dan J Birmingham, Deh-Ming Chang, Chung Jen Chen, Deborah McCurdy, Humeira M Badsha, Bernard Y H Thong, Hiok H Chng, Frank C Arnett, Daniel J Wallace, C Yung Yu, Bevra H Hahn, Rita M Cantor, Betty P Tsao.   

Abstract

A genomic region on distal mouse chromosome 1 and its syntenic human counterpart 1q23-42 show strong evidence of harboring lupus susceptibility genes. We found evidence of linkage at 1q32.2 in a targeted genome scan of 1q21-43 in 126 lupus multiplex families containing 151 affected sibpairs (nonparametric linkage score 2.52, P = 0.006). A positional candidate gene at 1q32.2, complement receptor 2 (CR2), is also a candidate in the murine Sle1c lupus susceptibility locus. To explore its role in human disease, we analyzed 1,416 individuals from 258 Caucasian and 142 Chinese lupus simplex families and demonstrated that a common three-single-nucleotide polymorphism CR2 haplotype (rs3813946, rs1048971, rs17615) was associated with lupus susceptibility (P = 0.00001) with a 1.54-fold increased risk for the development of disease. Single-nucleotide polymorphism 1 (rs3813946), located in the 5' untranslated region of the CR2 gene, altered transcriptional activity, suggesting a potential mechanism by which CR2 could contribute to the development of lupus. Our findings reveal that CR2 is a likely susceptibility gene for human lupus at 1q32.2, extending previous studies suggesting that CR2 participates in the pathogenesis of systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360460      PMCID: PMC1820691          DOI: 10.1073/pnas.0609101104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  CD21 is a ligand for CD23 and regulates IgE production.

Authors:  J P Aubry; S Pochon; P Graber; K U Jansen; J Y Bonnefoy
Journal:  Nature       Date:  1992-08-06       Impact factor: 49.962

2.  Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.

Authors:  A Fujisaku; J B Harley; M B Frank; B A Gruner; B Frazier; V M Holers
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

3.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Authors:  J D Fingeroth; J J Weis; T F Tedder; J L Strominger; P A Biro; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.

Authors:  H Molina; T Kinoshita; K Inoue; J C Carel; V M Holers
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

Review 5.  The genetics of human systemic lupus erythematosus.

Authors:  Betty P Tsao
Journal:  Trends Immunol       Date:  2003-11       Impact factor: 16.687

6.  A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus.

Authors:  Xiaobo Wu; Ning Jiang; Christine Deppong; Jasvinder Singh; Gregory Dolecki; Dailing Mao; Laurence Morel; Hector D Molina
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

7.  Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23.

Authors:  Rita M Cantor; Jinying Yuan; Susan Napier; Naoko Kono; Jennifer M Grossman; Bevra H Hahn; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2004-10

8.  Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).

Authors:  H V Marquart; A Svendsen; J M Rasmussen; C H Nielsen; P Junker; S E Svehag; R G Leslie
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.

Authors:  J G Wilson; W D Ratnoff; P H Schur; D T Fearon
Journal:  Arthritis Rheum       Date:  1986-06

10.  Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

Authors:  A X Delcayre; F Salas; S Mathur; K Kovats; M Lotz; W Lernhardt
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  30 in total

1.  Comparison of the gene expression profiles between gallstones and gallbladder polyps.

Authors:  Quanfu Li; Xin Ge; Xu Xu; Yonggang Zhong; Zengwang Qie
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection.

Authors:  R Herrero; L M Real; A Rivero-Juárez; J A Pineda; Á Camacho; J Macías; M Laplana; P Konieczny; F J Márquez; J C Souto; J M Soria; I Saulle; S Lo Caputo; M Biasin; A Rivero; J Fibla; A Caruz
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

Review 3.  Genetics of SLE: evidence from mouse models.

Authors:  Laurence Morel
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

Review 4.  The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.

Authors:  Adam J Fike; Irina Elcheva; Ziaur S M Rahman
Journal:  Curr Rheumatol Rep       Date:  2019-01-23       Impact factor: 4.592

Review 5.  Pathways: Strategies for susceptibility genes in SLE.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Autoimmun Rev       Date:  2010-02-08       Impact factor: 9.754

6.  Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor γ.

Authors:  Daniel J Perry; Yiming Yin; Tiffany Telarico; Henry V Baker; Igor Dozmorov; Andras Perl; Laurence Morel
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

7.  A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.

Authors:  Valeria Orrú; Sophia J Tsai; Blanca Rueda; Edoardo Fiorillo; Stephanie M Stanford; Jhimli Dasgupta; Jaana Hartiala; Lei Zhao; Norberto Ortego-Centeno; Sandra D'Alfonso; Frank C Arnett; Hui Wu; Miguel A Gonzalez-Gay; Betty P Tsao; Bernardo Pons-Estel; Marta E Alarcon-Riquelme; Yantao He; Zhong-Yin Zhang; Hooman Allayee; Xiaojiang S Chen; Javier Martin; Nunzio Bottini
Journal:  Hum Mol Genet       Date:  2008-11-03       Impact factor: 6.150

8.  Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells.

Authors:  C M Cuda; L Zeumer; E S Sobel; B P Croker; L Morel
Journal:  Genes Immun       Date:  2010-05-06       Impact factor: 2.676

9.  European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus.

Authors:  Sharon A Chung; Chao Tian; Kimberly E Taylor; Annette T Lee; Ward A Ortmann; Geoffrey Hom; Robert R Graham; Joanne Nititham; Jennifer A Kelly; Jean Morrisey; Hui Wu; Hong Yin; Marta E Alarcón-Riquelme; Betty P Tsao; John B Harley; Patrick M Gaffney; Kathy L Moser; Susan Manzi; Michelle Petri; Peter K Gregersen; Carl D Langefeld; Timothy W Behrens; Michael F Seldin; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-08

10.  Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.

Authors:  K B Douglas; D C Windels; J Zhao; A V Gadeliya; H Wu; K M Kaufman; J B Harley; J Merrill; R P Kimberly; G S Alarcón; E E Brown; J C Edberg; R Ramsey-Goldman; M Petri; J D Reveille; L M Vilá; P M Gaffney; J A James; K L Moser; M E Alarcón-Riquelme; T J Vyse; G S Gilkeson; C O Jacob; J T Ziegler; C D Langefeld; D Ulgiati; B P Tsao; S A Boackle
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.